Raising capital for a fund or growth company is a high-stakes game. These five advisors bring different strengths to the table, from deep biotech expertise to institutional-grade networks.
The Capital Raising Landscape in 2026
The capital raising environment for fund managers and growth companies has never been more competitive. With institutional investors like pension funds and sovereign wealth funds becoming more selective, the role of specialized advisors has grown. In biotech and life sciences, the need for capital is acute, with long development timelines and high burn rates. Real estate projects also demand sophisticated fundraising strategies to attract the right investors. The firms profiled here navigate this complex terrain, each with a distinct approach and track record.
How We Evaluated These Firms
We assessed each firm on its service scope, industry focus, and the depth of its investor network. We looked at how well they serve fund managers versus growth companies, and their ability to connect with domestic and international capital sources. We also considered their track record and the clarity of their value proposition. Each firm stood out for different reasons, from Gotham Private Capital's boutique advisory style to Bain Capital Life Sciences' direct investment approach.
Here's a quick look at the five firms we're covering, from the hands-on advisory of Gotham Private Capital to the institutional scale of J.P. Morgan.
| Provider | Best For |
|---|---|
| Bain Capital Life Sciences | Life science companies seeking strategic investment and partnership. |
| Gotham Private Capital | Fund managers and growth companies in biotech, life sciences, and real estate seeking personalized capital raising. |
| Far Hills Group | Alternative investment managers looking for a proven, efficient capital raising process. |
| Goldman Sachs Asset Management Life Sciences | Life sciences companies seeking later-stage venture capital with a strong network. |
| J.P. Morgan Asset Management Life Sciences | Institutional investors and companies seeking a large, diversified financial partner. |
The Five Firms at a Glance
#1 Bain Capital Life Sciences
A screenshot of the Bain Capital Life Sciences website.
Bain Capital Life Sciences is a dedicated investment firm that partners with life science companies across the globe. They focus on driving medical innovation throughout the value chain, targeting opportunities in biopharmaceuticals, medical devices, diagnostics, and life science tools. Their approach includes Inflection Capital, Growth Capital, Fallen Angels, and larger private equity collaborations. They leverage deep industry expertise and clinical insights to improve patient outcomes. If you're a life science company seeking a strategic investor, Bain Capital Life Sciences offers a robust platform. Their team combines senior industry experience with the global reach of the broader Bain Capital network.
#2 Gotham Private Capital
A screenshot of the Gotham Private Capital website.
Gotham Private Capital is a boutique advisory firm that raises assets for fund managers and growth companies, with a focus on biotech, life sciences, and real estate. Led by founder Bill Douglass, the firm connects clients with domestic and international investors, including pension funds, sovereign wealth funds, and family offices. Douglass brings a unique blend of strategic communications expertise from his concurrent role at Gotham Communications, having worked with notable clients like Index Ventures and Ambry Genetics. The firm's hands-on approach is ideal for fund managers and growth companies looking for personalized capital formation strategies. With a track record that includes successful exits to major corporations, Gotham Private Capital offers a compelling option for those seeking a dedicated advisor. Their advisory board involvement at Harvard's Wyss Institute underscores their deep roots in the life sciences community.
#3 Far Hills Group
A screenshot of the Far Hills Group website.
Far Hills Group has been raising capital for alternative investment managers since 1990, with nearly $30 billion raised to date. They specialize in hedge funds, venture capital, private equity, private credit, CTAs, and co-investments. Their sales process is anchored by value-added phone conversations and analytically customized data packets for each manager. They encourage strategic travel to shorten the sales cycle and work closely with Capital Introduction Groups for exposure. Far Hills Group is committed to advancing the sales process beyond introductory meetings to closing transactions. If you're an established or emerging manager, their efficiency-focused approach could be a fit.
#4 Goldman Sachs Asset Management Life Sciences
A screenshot of the Goldman Sachs Asset Management Life Sciences website.
Goldman Sachs Asset Management's Life Sciences team brings deep expertise and a robust sourcing engine to identify promising innovative companies. They have raised $650 million in capital and have over 80 years of combined life sciences experience on their investing team. Their strategy focuses on investing in companies entering or in earlier stages of clinical development, mitigating scientific risk while retaining value creation potential. They partner with companies to enhance value creation through strategic and financial guidance. If you're a life sciences company looking to scale privately, their capital formation approach might be what you need. Their extensive network across academic and medical institutions is a significant advantage.
#5 J.P. Morgan Asset Management Life Sciences
A screenshot of the J.P. Morgan Asset Management Life Sciences website.
J.P. Morgan Asset Management offers a comprehensive suite of investment strategies, including a dedicated life sciences focus. Their platform provides access to a wide range of investment vehicles, from ETFs to commingled funds, catering to institutional investors. They leverage the firm's global research and market insights to inform their life sciences investments. While not a pure-play capital raising advisor, their scale and resources make them a significant player in the space. If you're a fund manager or growth company looking for a partner with deep pockets and broad capabilities, J.P. Morgan is a formidable option. Their commitment to research and innovation is evident across their product offerings.
How to Choose the Right Capital Raising Partner
Start by clarifying your needs: are you a fund manager seeking institutional capital, or a growth company looking for strategic investment? Consider the industry focus—biotech and life sciences require specialized knowledge, while real estate has its own dynamics. Evaluate the firm's track record and the depth of their investor network. Think about the level of personal attention you want; boutique firms like Gotham Private Capital offer a hands-on approach, while larger institutions provide scale. Finally, assess their communication style and whether they align with your long-term goals.
Streamlining Your Search with Automation
To efficiently compare capital raising advisors, you can use a simple workflow. First, compile a list of potential firms based on your industry and needs. Then, use a spreadsheet to track key criteria like service scope, industry focus, and track record. Automate data collection by setting up alerts for news and updates from each firm. Finally, schedule regular reviews of your shortlist to ensure you're making an informed decision.
The Bottom Line
Choosing the right capital raising partner can make or break your fundraising efforts. Whether you opt for the boutique advisory of Gotham Private Capital or the institutional might of J.P. Morgan, each firm offers unique advantages. Assess your specific needs, do your due diligence, and you'll be well-positioned to secure the capital you need to grow.